GSK to invest £275m in UK

Production boost for sites in Durham, Herfordshire and Scotland

Call for tests after prostate cancer rise

Increase in US may help end opposition to screening

T cell attacking cancer cell. 3D computer illustration of a T lymphocyte white blood cell (white) destroying a cancerous cell (purple). T lymphocytes, or T cells, are a type of white blood cell and a component of the body's immune system. They recognise a specific site on the surface of a pathogen or foreign object (antigen), bind to it, and produce antibodies or cells to eliminate it.
©Science Photo Library

Gene therapy: A controversial cure

Recent deaths raise fears that a treatment for blood cancers is being brought to market too quickly

Rivals for ‘off-the-shelf’ cancer remedy

Companies are developing products that modify cells taken from the patient’s own blood

Cancer drugs aim to destabilise cell DNA

£6m project will focus on disrupting DNA repair of cancer cells

UK-exposed stocks sink on slowdown fears

But FTSE reaches highest in almost a year on overseas-oriented equities

US moves to block health insurer mergers

DoJ sues over Anthem’s takeover of Cigna and Aetna’s Humana deal

The limits of UK industrial strategy

May should beware the unintended consequences of state intervention, writes Geoffrey Owen

NHS head calls for pledge on EU staff

Government needs extra £500m a year to replace research funding

Novartis braced for US pricing shake-up

Swiss group warns of fallout from presidential election

Celgene in partnership to fight cancer

Biotech signs deal worth up to $2.6bn with start-up

Aids fight endangered by complacency

Global total of 36m people living with HIV is highest ever

Teva finalises bond sale of $15bn

Debt offering proceeds will fund Allergan drug unit purchase

Arm deal puts focus on UK industrial strategy

Theresa May promised more scrutiny of foreign takeovers

Sardinian genetic data sought for biobank

DNA gathered from region boasting wealth of centenarians

Pessimism over innovation just won’t fly

The Wright brothers typified self-motivated ‘civic entrepreneurs’

Herbalife reaches $200m FTC settlement

Hedge fund manager Bill Ackman allegations of pyramid scheme not upheld by regulator

Priory takeover set for competition probe

Fears that merger with Arcadia will raise prices for local authorities

Former Valeant chief sells $100m of shares

Drugmaker insists sale is ‘not a reflection’ on its viability

Staff with autism can offer rare skills

Some people on the spectrum excel at IT


More FT Twitter accounts